Business
US Health Officials' Approval Process for Biogen's Controversial Alzheimer's Drug Was ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'US health officials’ approval process for Biogen's controversial Alzheimer’s drug was “rife with irregularities,” congressional investigators say ...'
US health officials’ approval process for Biogen's controversial Alzheimer’s drug was “rife with irregularities,” congressional investigators say https://t.co/r26n64Rrdb— Bloomberg (@business) December 29, 2022
(The above story first appeared on LatestLY on Dec 30, 2022 02:04 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
